Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-08 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
690 | $15.26 | $10,532 | 268,854 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:03 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,005 | $15.96 | $32,002 | 254,644 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 7:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,197 | $25.41 | $55,835 | 256,649 (Direct) |
View |
| 2022-04-21 Sale |
2022-04-21 6:32 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,197 | $20.42 | $44,872 | 257,229 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
856 | $16.85 | $14,420 | 294,726 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
775 | $17.75 | $13,758 | 246,982 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:50 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
780 | $34.57 | $26,968 | 237,253 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 3:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
15,000 | $30 | $450,000 | 375,489 (Indirect Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 9:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
15,000 | $30 | $450,000 | 389,235 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-06 6:56 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
54,400 | $0 | 309,044 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:47 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
48,600 | $0 | 294,726 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:52 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
38,300 | $0 | 275,553 (Direct) |
View |
Ownership |
2021-02-16 7:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
0 | $0 | 238,033 (Indirect) |
View |
| 2020-12-18 Ownership |
2021-02-16 7:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
12,500 | $0 | 238,033 (Direct) |
View |